Topic Hub

Age V2 Rybelsus

2 clinically reviewed articles, written and peer-reviewed by the WomanRx.com Medical Team.

2articles

18keywords mapped

2025-01-28latest review

Explore

Age V2 Rybelsus library

Showing 2 of 2 clinical reviews.

Safety2025-01-28

Rybelsus (Oral Semaglutide) in Adolescent Girls Ages 12 to 17: Developmental Impact, Safety, and What Parents Need to Know

What does Rybelsus do to a teenage girl's development? Evidence on growth, puberty, bone, hormones, and pregnancy risk in girls ages 12 to 17.

Read clinical review

Safety2025-01-28

Rybelsus (Oral Semaglutide) in Women 65 and Older: What You Need to Know

How does Rybelsus affect women 65+? Geriatric dosing, safety, bone health, muscle loss, and what post-menopausal physiology changes about GLP-1 therapy.

Read clinical review